-
Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling
Koelink, P. J., Bloemendaal, F. M., Li, B., Westera, L., Vogels, E. W. M., van Roest, M., Gloudemans, A. K., van't Wout, A. B., Korf, H., Vermeire, S. V., te Velde, A. A., Ponsioen, C. Y., D'Haens, G. R. A. M., Verbeek, J. S., Geiger, T. L., Wildenberg, M. E. & van den Brink, G. R., 1 Jun 2020, In: Gut. 69, 6, p. 1053-1063 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Macrophages as a therapeutic target in inflammatory bowel disease: Lessons learned from anti-TNF therapy
Houttuijn Bloemendaal, F. M., 2020, 145 p.Research output: PhD thesis › Thesis, fully internal
-
TNF-anti-TNF immune complexes inhibit IL-12/IL-23 secretion by inflammatory macrophages via an fc-dependent mechanism
Bloemendaal, F. M., Koelink, P. J., van Schie, K. A., Rispens, T., Peters, C. P., Buskens, C. J., van der Bilt, J. D., Bemelman, W. A., Korf, H., Sabino, J. G., Ponsioen, C. Y., te Velde, A. A., D'Haens, G. R. A. M., Vermeire, S., van den Brink, G. R. & Wildenberg, M. E., 2018, In: Journal of Crohn s & colitis. 12, 9, p. 1122-1130Research output: Contribution to journal › Article* › Academic › peer-review
- All publications